Predicting the Clinical Advantages of Speaking Valves Through Wearable Devices A Prospective Cohort Study

What this Trial Is About

Researchers are studying the clinical benefits of using speaking valves in patients with tracheostomies who are admitted to the pulmonary department and undergoing decannulation rehabilitation. The study focuses on patients who are clinically stable and have been weaned off mechanical ventilation. It aims to compare changes in physiological parameters and clinical index metrics before and after using the speaking valve to better understand its effects during the decannulation process. The study involves having patients wear a speaking valve continuously for 30 minutes, which replaces the traditional capping method used in decannulation. The monitoring period with wearable biosensors covers 1 hour before the valve use, the 30-minute valve wearing period, and 1 hour after removal, totaling 2 hours and 30 minutes. Researchers will collect continuous, high-resolution physiological data during baseline, valve wear, and recovery phases to evaluate oxygen saturation changes, cardiovascular responses, and respiratory phase variations. Participants will be closely observed during the valve wearing process to ensure stable breathing, heart rate, blood pressure, and oxygen saturation without significant distress or frequent sputum blockage. The study measures the degree of change in oxygen saturation, cardiovascular asymmetry, autonomic recovery, and respiratory phase variation. The total monitoring and data collection time is about two and a half hours, and safety and tolerability are carefully tracked throughout the study period.

Predicting the Clinical Advantages of Speaking Valves Through Wearable Devices